L-citrulline recycling by argininosuccinate synthetase and lyase in rat gastric fundus

Eur J Pharmacol. 2002 Nov 29;455(2-3):149-60. doi: 10.1016/s0014-2999(02)02584-0.

Abstract

The aim of this study was to investigate in rat gastric fundus whether L-citrulline, the co-product in the nitric oxide (NO) biosynthesis catalyzed by neuronal nitric oxide synthase (nNOS), can be converted back to the nNOS substrate L-arginine. Immunohistochemistry showed that argininosuccinate synthetase and argininosuccinate lyase, that mediate transformation of L-citrulline to L-arginine in the ureum cycle in hepatocytes, co-localize with nNOS. In longitudinal smooth muscle strips, L-arginine as well as L-citrulline (10(-3) M) was capable of completely respectively partially preventing the N(G)-nitro-L-arginine methyl ester (L-NAME) (3 x 10(-5) M)-induced inhibition of electrically induced nitrergic relaxations, whereas D-citrulline (10(-3) M) was not. The L-citrulline-mediated prevention of the L-NAME-induced inhibition was reduced by L-glutamine (3 x 10(-3) M), the putative L-citrulline uptake inhibitor, and by succinate, an argininosuccinate lyase inhibitor. The results demonstrate that the L-citrulline recycling mechanism is active in rat gastric fundus. Recycling of L-citrulline might play a role in providing sufficient amounts of nNOS substrate during long-lasting relaxations in gastric fundus after food intake.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginase / pharmacology
  • Arginine / metabolism
  • Arginine / pharmacology
  • Argininosuccinate Lyase / antagonists & inhibitors
  • Argininosuccinate Lyase / metabolism*
  • Argininosuccinate Synthase / antagonists & inhibitors
  • Argininosuccinate Synthase / metabolism*
  • Argininosuccinic Acid / pharmacology
  • Aspartic Acid / pharmacology
  • Citrulline / metabolism*
  • Citrulline / pharmacology
  • Dinoprost / pharmacology
  • Electric Stimulation
  • Enzyme Inhibitors / pharmacology
  • Gastric Fundus / enzymology
  • Gastric Fundus / metabolism*
  • Glutamic Acid / pharmacology
  • Glutamine / pharmacology
  • In Vitro Techniques
  • Male
  • Muscle Relaxation / drug effects
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / physiology
  • N-Methylaspartate / pharmacology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type I
  • Rats
  • Rats, Wistar
  • Thiolester Hydrolases / metabolism
  • Ubiquitin Thiolesterase

Substances

  • Enzyme Inhibitors
  • Glutamine
  • Argininosuccinic Acid
  • Citrulline
  • Aspartic Acid
  • Glutamic Acid
  • N-Methylaspartate
  • Arginine
  • Dinoprost
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type I
  • Nos1 protein, rat
  • Thiolester Hydrolases
  • Ubiquitin Thiolesterase
  • Arginase
  • Argininosuccinate Lyase
  • Argininosuccinate Synthase
  • NG-Nitroarginine Methyl Ester